Expression of Programmed Cell Death-1 (PD-1) and Its Ligand (PD-L1) in Breast Cancers and Its Association with Clinicopathological Parameters: A Study from North India
Introduction Cancer immunotherapy targeting the programmed cell death ligand 1 (PD-L1) and programmed cell death-1 (PD-1) axis has revolutionized cancer therapy. PD-L1 also serves as a predictive marker for such therapy. To assess the potential of such therapy in any cancer, the positivity of PD-1 a...
Saved in:
Main Authors: | , , , , , , , |
---|---|
Format: | article |
Language: | EN |
Published: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/3e7680abb3dd43d2ad4124ebd1b85cd7 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|